- Patent Title: Genetic products differentially expressed in tumors and use thereof
-
Application No.: US13796094Application Date: 2013-03-12
-
Publication No.: US09637794B2Publication Date: 2017-05-02
- Inventor: Ugur Sahin , Özlem Türeci , Michael Koslowski
- Applicant: BioNTech AG
- Applicant Address: DE Mainz
- Assignee: BIONTECH AG
- Current Assignee: BIONTECH AG
- Current Assignee Address: DE Mainz
- Agency: McAndrews, Held & Malloy, Ltd.
- Priority: DE102-11-088 20020313
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07K14/47 ; C07K16/30 ; A61K39/395 ; A61K38/00 ; A61K39/00 ; A61K48/00 ; G01N33/574
Abstract:
The invention relates to the identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which the genetic products that are expressed in association with a tumor are expressed in an aberrant manner. The invention also relates to proteins, polypeptides, and peptides which are expressed in association with a tumor and the nucleic acids coding therefor.
Public/Granted literature
- US20130243796A1 GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND USE THEREOF Public/Granted day:2013-09-19
Information query
